In contrast, psoriasis vulgaris is a skin disease with a clearer pathogenesis (main role of the IL-23-IL-17 pathway), no skin destruction, and effective therapies, making this disease ideal for adequate overall medical care, at least in Western countries (34, 38). The gene discussed is IL17A; the disease is psoriasis vulgaris.